HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GENFLEET-B

28.160

-3.900-12.16%

Volume:6.59M

Turnover:191.35M

Market Cap:10.79B

PE:-4.64

High:32.900

Open:31.600

Low:27.740

Close:32.060

52wk High:52.900

52wk Low:19.600

Shares:383.00M

HK Float Shares:351.00M

Volume Ratio:4.51

T/O Rate:1.88%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-6.070

ROE:--

ROA:-19.54%

PB:5.74

PE(LYR):-4.64

PS:109.67

Loading ...

Overview Company News Filings

GenFleet to Unveil Early Clinical Results for KRAS G12D Inhibitor GFH375 and Pan-RAS Candidate GFH276; Investor Calls and ESMO Late-Breaking Abstract Confirmed

Bulletin Express

GENFLEET-B (02595) Outlines Schedule for Upcoming Clinical Data Presentations Concerning GFH375 and GFH276

GenFleet Schedules Oct. 15 Investor Call to Release Preliminary Gfh375-Cetuximab Trial Data in KRAS G12D Tumors

GenFleet Therapeutics (Shanghai) Says Gfh375 Combined with Cetuximab Placed on Proposed BTD List

Hong Kong Stock Market News Roundup: Insilico Medicine Secures Multi-Million-Dollar AI Collaboration Deal

GenFleet Therapeutics’ GFH375-Cetuximab Regimen Advances to China’s Proposed Breakthrough Therapy List

Bulletin Express

Genfleet Therapeutics (Shanghai) - Gfh375 Combined with Cetuximab Placed on Proposed Breakthrough Therapy Designation List by Nmpa on SEP 18

THOMSON REUTERS

HK-Listed GenFleet Rises Most in a Month on Repurchasing Shares

GENFLEET-B (02595) Posts HK$1.125 Billion Transfer in Share Movement, Accounting for 12.80% of Holdings

GENFLEET-B Announces H-Share Buyback Totaling 872,000 Shares as of September 18

GenFleet Reports Progress on 2026 H-Share Buyback: 872,000 Shares Repurchased, Equal to 0.227% of Share Capital

Bulletin Express

GenFleet Therapeutics Repurchases 319,000 H-Shares for HK$8.12 Million

Bulletin Express

GENFLEET-B Repurchases 63,000 Shares for Approximately HK$1.57 Million

GenFleet Therapeutics Executes HKD 4.22 Million Share Buyback, Reducing Free Float by 0.048%

Bulletin Express

GENFLEET-B (02595) Spends Approximately HK$4.22 Million on Share Buyback on September 16

GenFleet Therapeutics 1H26: Loss Contracts to RMB 220.17 million as Cash Reserves Hold at RMB 1.78 billion

Bulletin Express

GenFleet Therapeutics Executes 50,000-Share Buyback, Outstanding H-Share Float Slips to 351.31 Million

Bulletin Express

GENFLEET-B Buys Back 50,000 Shares for HK$1.30 Million on September 15

GenFleet Presents Updated Lung Cancer Therapy Data at Korean Medical Conference

MT Newswires Live

GENFLEET-B (02595) Presents Encouraging Phase II Monotherapy Results for Oral KRAS G12D Inhibitor in Pretreated NSCLC at WCLC 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/02595/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02595","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","market":"HK","secType":"STK","nameCN":"GENFLEET-B","latestPrice":28.16,"timestamp":1791446897006,"preClose":32.06,"halted":0,"volume":6586200,"delay":0,"changeRate":-0.1216469120399252,"floatShares":351000000,"shares":383000000,"eps":-6.07,"marketStatus":"Closed","change":-3.9,"latestTime":"10-08 16:08:17","open":31.6,"high":32.9,"low":27.74,"amount":191349457,"amplitude":0.160948,"askPrice":28.16,"askSize":9000,"bidPrice":28.12,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-3.946,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":5,"adr":0,"listingDate":1758211200000,"exchange":"SEHK","adjPreClose":32.06,"openAndCloseTimeList":[[1791423000000,1791432000000],[1791435600000,1791446400000]],"volumeRatio":4.50988,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02595\",,,,,undefined,":{"symbol":"02595","floatShares":351000000,"roa":"-19.54%","roe":"--","lyrEps":-6.07,"volumeRatio":4.50988,"shares":383000000,"dividePrice":0,"high":32.9,"amplitude":0.160948,"preClose":32.06,"low":27.74,"week52Low":19.6,"pbRate":"5.74","psRate":"109.67","week52High":52.9,"institutionHeld":0,"latestPrice":28.16,"committee":-0.875,"eps":-6.07,"divideRate":0,"volume":6586200,"delay":0,"ttmEps":-3.946,"open":31.6,"prevYearClose":23.78,"prevWeekClose":31.94,"prevMonthClose":33,"prevQuarterClose":33,"fiveDayClose":33,"twentyDayClose":26.3,"sixtyDayClose":42.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02595\",params:#limit:5,,,undefined,":[{"date":"2026-08-21","symbol":"02595","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787275800000,"name":null,"time":"","dateTimestamp":1787241600000,"actualEps":null},{"date":"2026-03-24","symbol":"02595","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774315800000,"name":null,"time":"","dateTimestamp":1774281600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02595\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02595\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1788105600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02595\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02595","date":"2026-10-07","current":-7.136341,"percent":0.682353,"low":-19.62221,"twenty":-10.688438,"median":-9.045193,"eighty":-7.05968,"high":-5.69787,"avg":-9.246376,"sd":2.656034,"marketCap":11873954157},"quantilePoints":[{"date":"2025-09-19","current":-19.62221,"twenty":-19.62221,"median":-19.62221,"eighty":-19.62221,"marketCap":14538840523},{"date":"2025-09-26","current":-17.850791,"twenty":-18.989349,"median":-18.569255,"eighty":-18.336187,"marketCap":13192012066},{"date":"2025-10-03","current":-19.06699,"twenty":-19.162092,"median":-18.845312,"eighty":-18.417026,"marketCap":14124431767},{"date":"2025-10-10","current":-11.809112,"twenty":-19.045684,"median":-18.645404,"eighty":-16.087956,"marketCap":11948785798},{"date":"2025-10-17","current":-10.861917,"twenty":-19.006201,"median":-18.336187,"eighty":-11.374297,"marketCap":10981832034},{"date":"2025-10-24","current":-9.567304,"twenty":-18.816504,"median":-12.899451,"eighty":-10.554523,"marketCap":9676444452},{"date":"2025-10-31","current":-9.989391,"twenty":-18.681528,"median":-11.762498,"eighty":-10.081819,"marketCap":10118416331},{"date":"2025-11-07","current":-9.878556,"twenty":-18.646705,"median":-10.725216,"eighty":-9.89625,"marketCap":9999899010},{"date":"2025-11-14","current":-11.674836,"twenty":-18.558233,"median":-10.712517,"eighty":-9.936062,"marketCap":11851732160},{"date":"2025-11-21","current":-10.329745,"twenty":-18.396816,"median":-10.725216,"eighty":-10.005136,"marketCap":10481375629},{"date":"2025-11-28","current":-10.423287,"twenty":-18.142029,"median":-10.678396,"eighty":-10.044836,"marketCap":10614707615},{"date":"2025-12-05","current":-10.100425,"twenty":-16.087956,"median":-10.631034,"eighty":-10.044836,"marketCap":10303599646},{"date":"2025-12-12","current":-10.212238,"twenty":-13.008301,"median":-10.584309,"eighty":-10.020393,"marketCap":10436931633},{"date":"2025-12-19","current":-9.790532,"twenty":-12.136764,"median":-10.450758,"eighty":-9.957409,"marketCap":10029528340},{"date":"2025-12-24","current":-8.945585,"twenty":-11.809112,"median":-10.416014,"eighty":-9.900509,"marketCap":9192499756},{"date":"2026-01-02","current":-8.020182,"twenty":-11.73453,"median":-10.320373,"eighty":-9.861601,"marketCap":8273990514},{"date":"2026-01-09","current":-11.588563,"twenty":-11.683046,"median":-10.309663,"eighty":-9.776189,"marketCap":11985064146},{"date":"2026-01-16","current":-11.693807,"twenty":-11.67863,"median":-10.369243,"eighty":-9.793132,"marketCap":12133210798},{"date":"2026-01-23","current":-10.361602,"twenty":-11.605818,"median":-10.329745,"eighty":-9.783265,"marketCap":10740632270},{"date":"2026-01-30","current":-10.919089,"twenty":-11.483053,"median":-10.385171,"eighty":-9.793132,"marketCap":11370255541},{"date":"2026-02-06","current":-11.146899,"twenty":-11.598147,"median":-10.450758,"eighty":-9.8258,"marketCap":11636919514},{"date":"2026-02-13","current":-10.659945,"twenty":-11.483053,"median":-10.58187,"eighty":-9.869606,"marketCap":11192479558},{"date":"2026-02-20","current":-10.145441,"twenty":-11.446311,"median":-10.573435,"eighty":-9.881527,"marketCap":10636929613},{"date":"2026-02-27","current":-9.574146,"twenty":-11.38719,"median":-10.509847,"eighty":-9.836956,"marketCap":10148045662},{"date":"2026-03-06","current":-8.841756,"twenty":-11.29428,"median":-10.416014,"eighty":-9.744297,"marketCap":9296202413},{"date":"2026-03-13","current":-10.316011,"twenty":-11.38719,"median":-10.450758,"eighty":-9.761464,"marketCap":10896186254},{"date":"2026-03-20","current":-10.186272,"twenty":-11.29428,"median":-10.385171,"eighty":-9.744297,"marketCap":10718410272},{"date":"2026-03-27","current":-5.945762,"twenty":-11.270982,"median":-10.329745,"eighty":-9.723416,"marketCap":12081359470},{"date":"2026-04-02","current":-6.621163,"twenty":-11.205287,"median":-10.312136,"eighty":-9.574146,"marketCap":13518381995},{"date":"2026-04-10","current":-7.067323,"twenty":-11.18954,"median":-10.310332,"eighty":-9.547859,"marketCap":14540593893},{"date":"2026-04-17","current":-8.194366,"twenty":-11.170082,"median":-10.271344,"eighty":-9.114302,"marketCap":16866496330},{"date":"2026-04-24","current":-11.736244,"twenty":-11.170082,"median":-10.248784,"eighty":-8.950161,"marketCap":18318333519},{"date":"2026-04-30","current":-10.233962,"twenty":-11.173069,"median":-10.230093,"eighty":-8.995356,"marketCap":15977616418},{"date":"2026-05-08","current":-9.881779,"twenty":-11.158327,"median":-10.186272,"eighty":-9.095725,"marketCap":15481325134},{"date":"2026-05-15","current":-8.422278,"twenty":-11.148553,"median":-10.161068,"eighty":-8.948635,"marketCap":13229496023},{"date":"2026-05-22","current":-7.916926,"twenty":-11.098455,"median":-10.138144,"eighty":-8.800358,"marketCap":12407282105},{"date":"2026-05-29","current":-8.035507,"twenty":-11.019944,"median":-10.082937,"eighty":-8.624127,"marketCap":12636909415},{"date":"2026-06-05","current":-6.909175,"twenty":-10.994143,"median":-10.039967,"eighty":-8.441141,"marketCap":10881371589},{"date":"2026-06-12","current":-6.584396,"twenty":-10.981505,"median":-9.989391,"eighty":-8.291507,"marketCap":10362858307},{"date":"2026-06-18","current":-6.718884,"twenty":-10.969649,"median":-9.941921,"eighty":-8.193596,"marketCap":10599892950},{"date":"2026-06-26","current":-5.732708,"twenty":-10.937065,"median":-9.927249,"eighty":-8.035507,"marketCap":8999909109},{"date":"2026-07-03","current":-7.180567,"twenty":-10.922684,"median":-9.900616,"eighty":-7.915515,"marketCap":11281367549},{"date":"2026-07-10","current":-9.054005,"twenty":-10.894174,"median":-9.893411,"eighty":-7.915515,"marketCap":14207263926},{"date":"2026-07-17","current":-8.396292,"twenty":-10.887172,"median":-9.884317,"eighty":-7.956496,"marketCap":13222088691},{"date":"2026-07-24","current":-8.187485,"twenty":-10.884642,"median":-9.862553,"eighty":-8.009423,"marketCap":12896166056},{"date":"2026-07-31","current":-6.510345,"twenty":-10.870773,"median":-9.833804,"eighty":-7.907869,"marketCap":10273970316},{"date":"2026-08-07","current":-7.003679,"twenty":-10.846908,"median":-9.792157,"eighty":-7.575355,"marketCap":11073962237},{"date":"2026-08-14","current":-7.214728,"twenty":-10.805358,"median":-9.754197,"eighty":-7.296139,"marketCap":11422106869},{"date":"2026-08-21","current":-7.917767,"twenty":-10.771121,"median":-9.6954,"eighty":-7.255608,"marketCap":12562836089},{"date":"2026-08-28","current":-7.346545,"twenty":-10.748709,"median":-9.635917,"eighty":-7.293508,"marketCap":11659141512},{"date":"2026-09-04","current":-6.41515,"twenty":-10.730984,"median":-9.570725,"eighty":-7.1768,"marketCap":10185082325},{"date":"2026-09-11","current":-5.935917,"twenty":-10.723237,"median":-9.522333,"eighty":-7.102704,"marketCap":9436941732},{"date":"2026-09-18","current":-6.230255,"twenty":-10.708658,"median":-9.391188,"eighty":-7.03728,"marketCap":9592495717},{"date":"2026-09-25","current":-7.20619,"twenty":-10.699734,"median":-9.151454,"eighty":-7.03728,"marketCap":11073962237},{"date":"2026-10-02","current":-7.689742,"twenty":-10.695182,"median":-9.058573,"eighty":-7.026079,"marketCap":11829510162},{"date":"2026-10-07","current":-7.707627,"twenty":-10.688438,"median":-9.045193,"eighty":-7.05968,"marketCap":11873954157}],"updateTime":1791448236135},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02595\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1188673295","title":"GenFleet to Unveil Early Clinical Results for KRAS G12D Inhibitor GFH375 and Pan-RAS Candidate GFH276; Investor Calls and ESMO Late-Breaking Abstract Confirmed","url":"https://stock-news.laohu8.com/highlight/detail?id=1188673295","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188673295?lang=en_us&edition=fundamental","pubTime":"2026-09-23 08:20","pubTimestamp":1790122833,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) has outlined a detailed timetable for the first public release of clinical data from two of its lead RAS pathway assets, GFH375 and GFH276. GFH375...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157523117","title":"GENFLEET-B (02595) Outlines Schedule for Upcoming Clinical Data Presentations Concerning GFH375 and GFH276","url":"https://stock-news.laohu8.com/highlight/detail?id=1157523117","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157523117?lang=en_us&edition=fundamental","pubTime":"2026-09-23 08:10","pubTimestamp":1790122216,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has issued a corporate update detailing the timeline for sharing clinical study findings tied to its lead assets, GFH375 and GFH276. The company has scheduled an online investor...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09939","159938","BK1515","BK1161","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669040178","title":"GenFleet Schedules Oct. 15 Investor Call to Release Preliminary Gfh375-Cetuximab Trial Data in KRAS G12D Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2669040178","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669040178?lang=en_us&edition=fundamental","pubTime":"2026-09-23 08:01","pubTimestamp":1790121670,"startTime":"0","endTime":"0","summary":"GenFleet schedules Oct. 15 investor call to release preliminary GFH375-cetuximab trial data in KRAS G12D tumorsGenFleet set October 15, 2026 for releasing preliminary study data on GFH375 combined wit","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDLHpMS9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK1161","02595","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669192180","title":"GenFleet Therapeutics (Shanghai) Says Gfh375 Combined with Cetuximab Placed on Proposed BTD List","url":"https://stock-news.laohu8.com/highlight/detail?id=2669192180","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669192180?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:42","pubTimestamp":1790041368,"startTime":"0","endTime":"0","summary":"BRIEF-GenFleet Therapeutics  Says GFH375 Combined With Cetuximab Placed On Proposed BTD ListSept 22 -GenFleet Therapeutics  Inc2595.HK:GFH375 COMBINED WITH CETUXIMAB PLACED ON PROPOSED BREAKTHROUGH THERAPY DESIGNATION LIST BY NMPA ON SEP 18Further company coverage:2595.HK","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45D0L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107498623","title":"Hong Kong Stock Market News Roundup: Insilico Medicine Secures Multi-Million-Dollar AI Collaboration Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1107498623","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107498623?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:10","pubTimestamp":1790039423,"startTime":"0","endTime":"0","summary":"Key Developments: Huanchuang Technology (06802) plans a global offering of 11.5888 million shares, with listing expected on September 30. Nazhen Technology (09856) saw its Hong Kong public offering...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1589","VXUS","AIPO","BK1586","BK4588","BK1526","BK1151","LU2213484517.USD","00354","VTHR","CHAT","BK4585","KCAI","BK1141","BK1518","BK1155","01911","BK1147","QTOC","ARTY","03696","AGIX","02595","06936"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173983479","title":"GenFleet Therapeutics’ GFH375-Cetuximab Regimen Advances to China’s Proposed Breakthrough Therapy List","url":"https://stock-news.laohu8.com/highlight/detail?id=1173983479","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173983479?lang=en_us&edition=fundamental","pubTime":"2026-09-22 08:22","pubTimestamp":1790036533,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. reported that its combination regimen of GFH375 with cetuximab has been placed on the Center for Drug Evaluation (CDE) of China’s National Medical Products...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669199941","title":"Genfleet Therapeutics (Shanghai) - Gfh375 Combined with Cetuximab Placed on Proposed Breakthrough Therapy Designation List by Nmpa on SEP 18","url":"https://stock-news.laohu8.com/highlight/detail?id=2669199941","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669199941?lang=en_us&edition=fundamental","pubTime":"2026-09-22 08:02","pubTimestamp":1790035321,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45D0L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669132852","title":"HK-Listed GenFleet Rises Most in a Month on Repurchasing Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2669132852","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669132852?lang=en_us&edition=fundamental","pubTime":"2026-09-21 12:14","pubTimestamp":1789964099,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed GenFleet rises most in a month on repurchasing shares** Shares of GenFleet Therapeutics  Inc2595.HKrise 6.8% to HK$27.66, on course for their biggest one-day pct gain since August 20** Stock hits the highest point since September 8 in the third consecutive session of gain** China-based innovative drugs developer says it repurchased 872,000 H shares, or 0.227% of the issued share capital, on September 18** Company says it may continue to repurchase shares subject to market conditions** YTD, stock up 13.5%, Hang Seng Biotech Index.HSBIOup 15.9%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nL1N45D036:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193243078","title":"GENFLEET-B (02595) Posts HK$1.125 Billion Transfer in Share Movement, Accounting for 12.80% of Holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=1193243078","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193243078?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:30","pubTimestamp":1789950614,"startTime":"0","endTime":"0","summary":"According to the latest data from the Hong Kong Stock Exchange, on September 18, a significant position shift was observed in GENFLEET-B (02595), with the total market value of the transferred shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02595","09939","159938","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108446847","title":"GENFLEET-B Announces H-Share Buyback Totaling 872,000 Shares as of September 18","url":"https://stock-news.laohu8.com/highlight/detail?id=1108446847","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108446847?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:28","pubTimestamp":1789950501,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has disclosed that, as of September 18, 2026, the company executed a series of H-share repurchases on The Stock Exchange of Hong Kong Limited, accumulating a total of 872,000...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","02595","159938","BK1574","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151112895","title":"GenFleet Reports Progress on 2026 H-Share Buyback: 872,000 Shares Repurchased, Equal to 0.227% of Share Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=1151112895","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151112895?lang=en_us&edition=fundamental","pubTime":"2026-09-21 08:21","pubTimestamp":1789950091,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. disclosed that, as of 18 September 2026, it has repurchased an aggregate 872,000 H shares on The Stock Exchange of Hong Kong Limited under its 2026 buyback...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179120208","title":"GenFleet Therapeutics Repurchases 319,000 H-Shares for HK$8.12 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1179120208","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179120208?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:06","pubTimestamp":1789725975,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. completed an on-market repurchase of 319,000 H-shares on 18 September 2026, the company disclosed in a Next Day Disclosure Return filed with the Hong Kong Stock...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128161683","title":"GENFLEET-B Repurchases 63,000 Shares for Approximately HK$1.57 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1128161683","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128161683?lang=en_us&edition=fundamental","pubTime":"2026-09-17 20:54","pubTimestamp":1789649650,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has announced that on September 17, it spent approximately HK$1.5738 million to repurchase 63,000 shares at a price ranging from HK$24.78 to HK$25.10 per share.The share buyback...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09939","BK1161","02595","BK1515","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171703230","title":"GenFleet Therapeutics Executes HKD 4.22 Million Share Buyback, Reducing Free Float by 0.048%","url":"https://stock-news.laohu8.com/highlight/detail?id=1171703230","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171703230?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:44","pubTimestamp":1789555465,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. repurchased 169,000 H-shares on 16 September 2026, spending HKD 4.22 million on‐market. The shares were bought at prices ranging from HKD 24.78 to HKD 25.22,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115646954","title":"GENFLEET-B (02595) Spends Approximately HK$4.22 Million on Share Buyback on September 16","url":"https://stock-news.laohu8.com/highlight/detail?id=1115646954","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115646954?lang=en_us&edition=fundamental","pubTime":"2026-09-16 18:36","pubTimestamp":1789554974,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has announced that on September 16, 2026, the company expended approximately HK$4.2175 million to repurchase 169,000 shares.The repurchase price ranged from HK$24.78 to HK$25.22 per share, reflecting the company's ongoing capital management efforts.","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","159938","BK1161","02595","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172233546","title":"GenFleet Therapeutics 1H26: Loss Contracts to RMB 220.17 million as Cash Reserves Hold at RMB 1.78 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1172233546","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172233546?lang=en_us&edition=fundamental","pubTime":"2026-09-16 17:04","pubTimestamp":1789549474,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (GENFLEET-B) reported a markedly narrower interim loss for the six months ended 30 June 2026, driven by a one-off fair-value item in the prior-year base and higher interest...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"GenFleet Therapeutics 1H26: Loss Contracts to RMB 220.17 million as Cash Reserves Hold at RMB 1.78 billion","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141645949","title":"GenFleet Therapeutics Executes 50,000-Share Buyback, Outstanding H-Share Float Slips to 351.31 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1141645949","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141645949?lang=en_us&edition=fundamental","pubTime":"2026-09-15 18:24","pubTimestamp":1789467897,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics (Shanghai) Inc. (GENFLEET-B) disclosed a Next Day Disclosure Return detailing the on-market repurchase of 50,000 H shares on 15 September 2026. The purchase, executed on the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150603956","title":"GENFLEET-B Buys Back 50,000 Shares for HK$1.30 Million on September 15","url":"https://stock-news.laohu8.com/highlight/detail?id=1150603956","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150603956?lang=en_us&edition=fundamental","pubTime":"2026-09-15 17:52","pubTimestamp":1789465934,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on September 15, 2026, the company spent HK$1.2956 million to repurchase 50,000 of its own shares.The share buyback represents the company's ongoing commitment to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159938","BK1574","09939","02595","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667613417","title":"GenFleet Presents Updated Lung Cancer Therapy Data at Korean Medical Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2667613417","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667613417?lang=en_us&edition=fundamental","pubTime":"2026-09-15 11:55","pubTimestamp":1789444542,"startTime":"0","endTime":"0","summary":"GenFleet Therapeutics  said Tuesday it presented the updated Phase 2 data for GFH375 monotherapy in pretreated KRAS G12D-mutant non-small cell lung cancer at the World Conference on Lung Cancer in South Korea.The company said the updated results showed an objective response rate of 59.2%, a disease control rate of 93%, and a 12-month overall survival rate of 77% in 71 subjects who received 600 milligrams of the oral drug, according to a Tuesday disclosure.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02595","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110963745","title":"GENFLEET-B (02595) Presents Encouraging Phase II Monotherapy Results for Oral KRAS G12D Inhibitor in Pretreated NSCLC at WCLC 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1110963745","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110963745?lang=en_us&edition=fundamental","pubTime":"2026-09-15 08:28","pubTimestamp":1789432097,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) has unveiled updated efficacy data from its Phase II trial evaluating GFH375 as a monotherapy for patients with pretreated KRAS G12D-mutant non-small cell lung cancer (NSCLC). The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02595","BK1515","09939","BK1574","159938","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":2,"totalSize":129,"code":"91000000","status":"200"}]}}